NCT03648632View on ClinicalTrials.gov

Stereotactic Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer (LAPC)

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 22, 2018

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Locally Advanced Pancreatic Cancer
Interventions
RADIATION

Stereotactic Radiotherapy

Patients should be treated with 50 Gy in 5 fractions within a total of 7 - 8 days.

Trial Locations (1)

5000

Odense University Hospital, Odense

All Listed Sponsors
lead

Per Pfeiffer

OTHER

NCT03648632 - Stereotactic Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer (LAPC) | Biotech Hunter | Biotech Hunter